Intraoral Versus Extraoral Manual Therapy in Subjects With Temporomandibular Disorders
- Conditions
- Temporomandibular Disorder
- Registration Number
- NCT05167656
- Lead Sponsor
- University of Alcala
- Brief Summary
The aim of this randomized controlled trial is to evaluate the effects of intraoral manual therapy versus extraoral manual therapy and compare them with a control group, in the management of patients with temporomandibular disorders regarding pain, strength, quality of life, disability and anxiety.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 90
- Unilateral temporomandibular pain for more than one month.
- Older than eighteen.
- No previous treatment to temporomandibular pain in the last 3 months.
- Diagnosed based on the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD).
- Patients with cervical or cranial trauma or whiplash.
- Diagnosed with systemic disease, like rheumatoid arthritis or fibromyalgia.
- Diagnosed of any vascular or metabolic disease.
- Previous cervical or temporomandibular surgery.
- Dental, medicine or any physical therapy treatment in the last 3 months before the beginning of the interventions.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Change in pain intensity Baseline, change from baseline at 3-week, change from baseline at 6-week, at 1 month after treatment, after 3 months after treatment, after 6 months after treatment. Pain intensity measured with numerical pain rating scale which ranges from 0 points (no pain) to 10 points (worst imaginable pain)
- Secondary Outcome Measures
Name Time Method Change in pain pressure threshold Baseline, change from baseline at 3-week, change from baseline at 6-week, at 1 month after treatment, after 3 months after treatment, after 6 months after treatment. Pain pressure threshold measured by a digital algometer at several locations of temporomandibular joint.
Change in range of movement of the temporomandibular joint Baseline, change from baseline at 3-week, change from baseline at 6-week, at 1 month after treatment, after 3 months after treatment, after 6 months after treatment. Active and passive range of movement measured by a digital caliper.
Change in quality of life Baseline, change from baseline at 3-week, change from baseline at 6-week, at 1 month after treatment, after 3 months after treatment, after 6 months after treatment. Quality of life measured with Short Form Health Survey (SF-12). SF-12 ranges from 0 (poor quality of life) to 100 (great quality of life).
Change in disability Baseline, change from baseline at 3-week, change from baseline at 6-week, at 1 month after treatment, after 3 months after treatment, after 6 months after treatment. Disability measured with Craniofacial Pain and Disability Inventory (CF-PDI). CF-PDI ranges from 0 (better functional status) to 63 (worse disability).
Change in anxiety Baseline, change from baseline at 3-week, change from baseline at 6-week, at 1 month after treatment, after 3 months after treatment, after 6 months after treatment. Anxiety measured with State-Trait Anxiety Inventory (STAI). STAI ranges from 20 (lower anxiety) to 80 (greater anxiety).
Trial Locations
- Locations (1)
University of Alcalá
🇪🇸Alcalá De Henares, Madrid, Spain
University of Alcalá🇪🇸Alcalá De Henares, Madrid, SpainJorge Ballesteros, PhD StudentContact638332255jorgeballes10@gmail.com